FibroGen and Regeneron Pharmaceuticals forge clinical trial collaboration for cancer treatment

Pallavi Madhiraju- June 4, 2024 0

FibroGen, Inc. (NASDAQ: FGEN) has entered into a clinical trial supply agreement with Regeneron Pharmaceuticals, aiming to evaluate FibroGen’s immuno-oncology assets, FG-3165 and FG-3175, in ... Read More